When available, the educational toolkit will provide patients with sickle cell disease information on the gene therapy process, what to expect from therapy, and the importance of follow-up care.

Some doctors told him he'd live with the disease forever, but Khaled Alsheebani never stopped believing treatments would advance one day.

Despite some recent setbacks to its sickle cell disease (SCD) pipeline, Pfizer is plowing ahead in improving education around ...

The FDA has granted orphan drug status to rilzabrutinib, an investigational therapy to prevent pain crises in sickle cell ...

A 30-year-old New Jersey woman was charged with two felonies after police said she lied about having sickle cell anemia and refused to pay for over $560,000 in treatment from a hospital in ...

A New York patient is the first in the state cured of sickle cell anemia The new Lyfgenia genetic treatment uses a patient’s ...

Sebastien Beauzile, 21, has been cured of sickle cell anemia, according to his doctors at Cohen’s Children’s Medical Center. Beauzile received a new gene therapy called Lyfgeni, created by the ...

He had come to Florida to surprise his sister for her birthday. But instead, he had become so weak from sickle cell anemia that he had to be carried into a local hospital, then sent to another ...

Many individuals with sickle cell anemia undergoing controlled ovarian hyperstimulation (COH) with oocyte cryopreservation (OC) have complications, according to a study scheduled for presentation ...

Sickle cell anemia may qualify as a disability for people experiencing severe symptoms, allowing access to benefits. However, eligibility depends on how the condition affects daily life.

September is National Sickle Cell Anemia Awareness Month. Sickle cell anemia is a disease that is inherited genetically through a trait passed to a child by both parents, affecting the blood cells.

Patients with sickle cell anemia (SCA) and persistent albuminuria (PA) exhibited significantly higher levels of urinary angiotensinogen (AGT). “What we’re most excited about is that urinary ...